NPS MedicineWise has issued a
special edition of its NPS RADAR
detailing changes to the National
Cervical Screening Program.
Effective 01 May 2017, Pap
smears will be replaced with HPV
testing of cervical samples with
partial HPV genotyping, and reflex
liquid-based cytology on samples
testing positive for HPV.
Until then it is business as usual,
with NPS’ Dr Robyn Lindner saying
women should not delay testing
under the current arrangements -
and HPV-vaccinated women should
still be tested because the current
vaccine doesn’t protect against all
cancer-causing HPV types .
Under the new system, screening
will start at age 25, the screening
interval will be extended to five
years and self-collection of a
cervical sample will be available for
under-screened women.The above article was sent to subscribers in Pharmacy Daily's issue from 01 Oct 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Oct 15
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
PHARMACY Connect (PC2024) has revealed that Olympian Peter Bol will be sharing his journey from adversity to athletic greatness at the conference in Sep in Sydney.
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.